A rumor regarding Viking Therapeutics (VKTX) was highlighted in an alert sent to subscribers of Ben Harrington’s takeover-focused Betaville ...

Viking Therapeutics (NASDAQ:VKTX) quickly soared 10% amid some renewed takeover speculation for the biotech firm. There's some renewed speculation Viking (NASDAQ:VKTX) may be a takeover target, ...

Bullish option flow detected in Viking Therapeutics (VKTX) with 61,052 calls trading, 8x expected, and implied vol increasing over 32 points to ...

We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going to ...

We recently published an article titled These 10 Companies Led Monday's Downturn. In this article, we are going to take a ...

B. Riley lowered the firm’s price target on Viking Therapeutics (VKTX) to $96 from $109 and keeps a Buy rating on the shares.

Viking Therapeutics Inc.’s stock jumped 3% Tuesday, after a bullish note from Oppenheimer highlighted the company’s promising obesity-drug program and its potential appeal to a deep-pocketed ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Viking Therapeutics have fallen by more than half since the stock peaked early last year. Viking Therapeutics is developing a drug that might be able to outperform today's most popular ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...